medigraphic.com
ISSN 2078-7170 (Electronic)

2019, Number 1

<< Back Next >>

CorSalud 2019; 11 (1)

Arrhythmias and sudden death in heart failure: electrical stratification of risk groups

Dorantes SM, Jerez CAM

Language: Spanish
References: 24
Page: 54-61
PDF size: 583.86 Kb.


ABSTRACT

In this research is presented an overview of heart failure related to arrhythmias and sudden death, which can coexist, worsen, or be cause or consequence of one another. Here are discussed the premonitory electrical signs that allow to stratify risk in patients with previous events, with a possible approach to reality, and in those who have not presented them (most of them, the unprotected ones) and where a prognosis is very difficult, or impossible, to be established. These signs are numerous, elusive, with low specificity and sensitivity, none is absolute or negligible, in order to interpret them, a comprehensive vision is required. Premature ventricular contractions are discussed as predictors and triggers of arrhythmias, sudden death and cardiomyopathy, as well as the usefulness of ablative procedures versus medications. Electrical signs are good for identifying large risk groups but not for identifying high risk individuals inside the large low risk group (the majority).


REFERENCES

  1. Alemán AA, Dorantes M. Marcadores electrocardiográficos de arritmias ventriculares malignas. Rev Cuban Cardiol Cir Cardiovasc [Internet]. 2012 [citado 4 Dic 2018];18(2):66-71. Disponible en: http://revcardiologia.sld.cu/index.php/revcardiologia/article/view/198/235

  2. Lane RE, Cowie MR, Chow AW. Prediction and prevention of sudden cardiac death in heart failure. Heart. 2005;91(5):674-80.

  3. Singh SN. Congestive heart failure and arrhythmias: therapeutic modalities. J Cardiovasc Electrophysiol. 1997;8(1):89-97.

  4. Stevenson WG, Sweeney MO. Arrhythmias and sudden death in heart failure. Jpn Circ J. 1997;61(9):727-40.

  5. Dorantes M. Signos eléctricos premonitorios de riesgo: ¿cuál es el mejor? Controversia no terminada, en impetuoso crecimiento. CorSalud [Internet]. 2010 [citado 5 Dic 2018];2(1):55-61. Disponible en: http://www.corsalud.sld.cu/sumario/2010/v2n1a10/signos.htm

  6. Kirchhof P, Franz MR, Bardai A, Wilde AM. Giant T-U waves precede torsades de pointes in long QT syndrome: a systematic electrocardiographic analysis in patients with acquired and congenital QT prolongation. J Am Coll Cardiol. 2009;54(2):143-9.

  7. Kenttä TV, Nearing BD, Porthan K, Tikkanen JT, Viitasalo M, Nieminen MS, et al. Prediction of sudden cardiac death with automated high-throughput analysis of heterogeneity in standard resting 12-lead electrocardiograms. Heart Rhythm. 2016;13(3):713-20.

  8. Wellens HJ. Forty years of invasive clinical electrophysiology 1967-2007.Circ Arrhythmia Electrophysiol. 2008;1:49-53.

  9. Boyden PA, Hirose M, Dun W. Cardiac Purkinje cells. Heart Rhythm. 2009;7(1):127-35.

  10. Ideker RE, Rogers J, Huang J. Types of ventricular fibrillation: 1, 2, 4, 5, or 300,000? J Cardiovasc Electrophysiol. 2004;15(12):1441-3.

  11. Ideker RE, Rogers JM. Human ventricular fibrillation. Wandering wavelets, mother rotors, or both? Circulation. 2006;114(6):530-2.

  12. Dukes JW, Dewland TA, Vittinghoff E, Mandyam MC, Heckbert SR, Siscovick DS, et al. Ventricular ectopy as a predictor of heart failure and death. J Am Coll Cardiol. 2015;66(2):101-9.

  13. Santangeli P, Marchlinski FE. Ventricular ectopy as a modifiable risk factor for heart failure and death: "déjà vu all over again" may be a good thing. J Am Coll Cardiol. 2015;66(2):110-2.

  14. Callans DJ, Epstein AE. Reflections on the lowly PVC. Heart Rhythm. 2015;12(4):714-5.

  15. Tomaselli GF. The consequences of contracting early and often. Heart Rhythm. 2014;11(11):2073-4.

  16. Lindsay BD. Eliminating triggers of ventricular fibrillation. The past, present, and future. J Am Coll Cardiol. 2009;54(6):529-30.

  17. Sullivan RM, Olshansky B. Treatment of PVCs post-myocardial infarction: Will we get fooled again? Heart Rhythm. 2009;6(11):1550-1.

  18. Latchamsetty R, Bogun F. Premature ventricular contraction ablation. How aggressive should we be? Card Electrophysiol Clin. 2012;4(3):439-45.

  19. Sarrazin JF, Labounty T, Kuhne M, Crawford T, Armstrong WF, Desjardins B, et al. Impact of radiofrequency ablation of frequent post-infarction premature ventricular complexes on left ventricular ejection fraction. Heart Rhythm. 2009;6(11):1543-9.

  20. Carballeira Pol L, Deyell MW, Frankel DS, Benhayon D, Squara F, Chik W, et al. Ventricular premature depolarization QRS duration as a new marker of risk for the development of ventricular premature depolarization-induced cardiomyopathy. Heart Rhythm. 2014;11(2):299-306.

  21. Cardiac Arrhythmia Suppression Trial (CAST) Investigators. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med. 1989;321(6):406-12.

  22. Cha YM, Redfield MM, Shen WK, Gersh BJ. Atrial fibrillation and ventricular dysfunction. A vicious electromechanical cycle. Circulation. 2004;109(23):2839-43.

  23. Marrouche NF, Brachmann J, Andresen D, Siebels J, Boersma L, Jordaens L, et al. Catheter ablation for atrial fibrillation with heart failure. N Engl J Med. 2018;378(5):417-27.

  24. Tornés FJ, Cisneros P, Dorantes M, Castro J, Zayas R, Quiñones MA,et al. Tormenta eléctrica arrítmica en pacientes con cardioversor-desfibrilador automático implantable. Arch Cardiol Mex. 2008;78(1):68-78.




2020     |     www.medigraphic.com